These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 350214)

  • 1. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an enteric coated aspirin preparation.
    Day RO; Paull PD; Champion GD; Graham GG
    Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
    Mielants H; Verbruggen G; Schelstraete K; Veys EM
    J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
    Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
    Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three slow-release acetylsalicylic acid preparations in rheumatoid arthritis.
    Martio J; Kahela P
    Scand J Rheumatol; 1983; 12(3):305-9. PubMed ID: 6623020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid)and other forms of salicylates.
    Mielants H; Veys EM; Verbruggen G; Schelstraete
    Scand J Rheumatol; 1981; 10(3):169-73. PubMed ID: 7027430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylate-induced occult gastrointestinal blood loss: comparison between different oral and parenteral forms of acetylsalicylates and salicylates.
    Mielants H; Veys EM; Verbruggen G; Schelstraete K
    Clin Rheumatol; 1984 Mar; 3(1):47-54. PubMed ID: 6331971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of enteric-coated penicillamine tablets.
    Chambliss WG; Chambliss DA; Cleary RW; Jones AB; Harland EC; Kibbe AH
    J Pharm Sci; 1984 Sep; 73(9):1215-9. PubMed ID: 6333505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of aspirin and enteric-coated aspirin on loss of chromium 51-labeled erythrocytes from the gastrointestinal tract.
    Robbins DC; Schwartz RS; Kutny K; Vallejo G; Horton ES; Cotter JM
    Clin Ther; 1984; 6(4):461-6. PubMed ID: 6331883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction in gastric mucosal hemorrhage and ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day.
    Lanza FL; Rack MF; Wagner GS; Balm TK
    Dig Dis Sci; 1985 Jun; 30(6):509-12. PubMed ID: 3873326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult gastrointestinal bleeding due to aspirin: comparison of two compounds.
    Rossouw JE; Clarke M; Davis M; Williams R
    Rheumatol Rehabil; 1976 Feb; 15(1):31-4. PubMed ID: 1082620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
    Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
    J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric-coated aspirin in rheumatoid arthritis.
    Bird HA; Rhind V; Leatham P; Saunders A; Wright V
    Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.